Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,564,500
-
Total 13F shares
-
19,482,171
-
Share change
-
+6,305,572
-
Total reported value
-
$612,517,952
-
Put/Call ratio
-
86%
-
Price per share
-
$31.44
-
Number of holders
-
87
-
Value change
-
+$196,917,062
-
Number of buys
-
72
-
Number of sells
-
16
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q3 2015
As of 30 Sep 2015 Atara Biotherapeutics, Inc. - Common Stock (ATRA) had 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,482,171 shares of stock of the company.
Largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, Redmile Group, LLC, JENNISON ASSOCIATES LLC, Visium Asset Management, LP, EcoR1 Capital, LLC, STATE STREET CORP, BAMCO INC /NY/, and BRIDGER MANAGEMENT, LLC.
This table shows 87 institutional shareholders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.